Skip to research content
Back to companies
BI

BioInvent International Aktiebolag

Healthcare

Last 12 months

EUR

Net buy/sell balance
€0.00
Public filings
0
Reported buys
€0.00
Reported sales
€0.00
Total reported value
€0.00
Other reported value
€0.00

Activity uses publication dates. This selector changes the chart only; the summary above shows the last 12 months.

Insider trades and share price

Monthly filing activity by publication date and share price, shown for context.

Insider filing data is still loading. Historical price data is still loading.

Loading chart data

Insider activity and price evolution

Signals Pro

Price change after the observation · 1, 3 and 6 months

Net buying
1 month: +0.8%
3 months: +2.9%
6 months: +6.1%
Net selling
1 month: -1.2%
3 months: -2.6%
6 months: -3.8%

Illustrative example with simulated data. These results do not describe this company.

What follows months of insider activity?

Compare monthly net buying and selling with subsequent price movements. Signals Pro quantifies the observed relationship and shows how much evidence supports it.

  • Rank association at the same month and after 1, 3 and 6 months
  • Median price changes after net buying and net selling
  • Sample sizes and evidence levels, without implying causality
Explore Signals Pro

Public filings

Open any row to inspect the regulatory record and its transactions.

All disclosed operations, including compensation and transfers. Values can represent transferred assets rather than cash invested.

DateInsiderRoleTotal reported valueOpen
4 Sept 2023Erik EsveldStyrelseledamotBuy

SEK 156,426.30

Buy/sale net: SEK 156,426.30

Open
31 Aug 2023Bernd SeizingerStyrelseledamotBuy

SEK 603,374.08

Buy/sale net: SEK 603,374.08

Open
18 Jul 2023Leonard KruimerStyrelseordförandeBuy

SEK 180,000.00

Buy/sale net: SEK 180,000.00

Open
13 Jul 2023Kristoffer BissessarStyrelseledamotBuy

SEK 238,000.00

Buy/sale net: SEK 238,000.00

Open
4 Jul 2023Sylvie RyckebuschAnnan medlem i bolagets administrations-, lednings- eller kontrollorganBuy

€7,890.00

Buy/sale net: €7,890.00

Open
14 Jun 2023BioInvent Finans ABNot availableDirection unavailable

Not available

Buy/sale net: Not available

Open
29 May 2023Leonard KruimerStyrelseordförandeBuy

SEK 127,250.00

Buy/sale net: SEK 127,250.00

Open

Erik Esveld

4 Sept 2023
Buy

Gross reported

SEK 156,426.30

Evidence

Bernd Seizinger

31 Aug 2023
Buy

Gross reported

SEK 603,374.08

Evidence

Leonard Kruimer

18 Jul 2023
Buy

Gross reported

SEK 180,000.00

Evidence
Buy

Gross reported

SEK 238,000.00

Evidence
Buy

Gross reported

€7,890.00

Evidence
Direction unavailable

Gross reported

Not available

Evidence

Leonard Kruimer

29 May 2023
Buy

Gross reported

SEK 127,250.00

Evidence

People and insiders

Filings in the last 12 months refer to this company. Luck factor covers the insider’s overall activity; timing uses episodes in this company.

Signals are not available for this disclosure jurisdiction.

InsiderFilings · 12 monthsLuck factorHit rateEpisodesTiming detail
Bernd SeizingerStyrelseledamot
0UnavailableUnavailable
BioInvent Finans ABSource role not reported
0UnavailableUnavailable
Erik EsveldStyrelseledamot
0UnavailableUnavailable
Kristoffer BissessarStyrelseledamot
0UnavailableUnavailable
Leonard KruimerStyrelseordförande
0UnavailableUnavailable
Stefan ErikssonEkonomichef/finanschef/finansdirektör
0UnavailableUnavailable
Sylvie RyckebuschAnnan medlem i bolagets administrations-, lednings- eller kontrollorgan
0UnavailableUnavailable

Evidence

Open a filing in the activity ledger to inspect its transactions, original regulatory document and source provenance.

Activity